| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.041 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |